1. |
Angelousi A, Hayes AR, Chatzellis E, et al. Metastatic medullary thyroid carcinoma: a new way forward. Endocr Relat Cancer, 2022, 29(7): R85-R103.
|
2. |
Gambardella C, Offi C, Patrone R, et al. Calcitonin negative medullary thyroid carcinoma: a challenging diagnosis or a medical dilemma? BMC Endocr Disord, 2019, 19(Suppl 1): 45. doi: 10.1186/s12902-019-0367-2.
|
3. |
Adam MA, Thomas S, Roman SA, et al. Rethinking the current american joint committee on cancer TNM staging system for medullary thyroid cancer. JAMA Surg, 2017, 152(9): 869-876.
|
4. |
Chen L, Wang Y, Zhao K, et al. Postoperative Nomogram for predicting cancer-specific and overall survival among patients with medullary thyroid cancer. Int J Endocrinol, 2020, 2020: 8888677. doi: 10.1155/2020/8888677.
|
5. |
Pavlidis E, Sapalidis K, Chatzinikolaou F, et al. Medullary thyroid cancer: molecular factors, management and treatment. Rom J Morphol Embryol, 2020, 61(3): 681-686.
|
6. |
Raue F, Frank-Raue K. Long-term follow-up in medullary thyroid carcinoma. Recent Results Cancer Res, 2015, 204: 207-225.
|
7. |
Kim TH, Kim YN, Kim HI, et al. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma. Oral Oncol, 2017, 71: 81-86.
|
8. |
Park SY, Cho YY, Kim HI, et al. Clinical validation of the prognostic stage groups of the eighth-edition TNM staging for medullary thyroid carcinoma. J Clin Endocrinol Metab, 2018, 103(12): 4609-4616.
|
9. |
Zhou TH, Zhao LQ, Zhang Y, et al. The prediction of metastases of lateral cervical lymph node in medullary thyroid carcinoma. Front Endocrinol (Lausanne), 2021, 12: 741289. doi: 10.3389/fendo.2021.741289.
|
10. |
Hassan A, Siddique M, Riaz S, et al. Medullary thyroid carcinoma: prognostic variables and tumour markers affecting survival. J Ayub Med Coll Abbottabad, 2018, 30(Suppl 1)(4): S627-S632.
|
11. |
Duh QY, Gosnell JE. Improvement of TNM staging for medullary thyroid cancer. JAMA Surg, 2017, 152(9): 876-877.
|
12. |
Matrone A, Gambale C, Prete A, et al. Impact of advanced age on the clinical presentation and outcome of sporadic medullary thyroid carcinoma. Cancers (Basel), 2020, 13(1): 94. doi: 10.3390/cancers13010094.
|
13. |
Gogna S, Goldberg M, Samson D, et al. Medullary thyroid cancer in patients older than 45-epidemiologic trends and predictors of survival. Cancers (Basel), 2020, 12(11): 3124. doi: 10.3390/cancers12113124.
|
14. |
Li M, Huang Y, Wang M, et al. A new proposed tumor-node-metastasis-age staging system for stage Ⅳ medullary thyroid carcinoma based on the SEER database. Am J Transl Res, 2021, 13(6): 6098-6107.
|
15. |
Meng K, Luo H, Chen H, et al. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: a population-based study using the SEER 18 database. Medicine (Baltimore), 2019, 98(1): e13884. doi: 10.1097/MD.0000000000013884.
|
16. |
Prassas D, Safi SA, Stylianidi MC, et al. N, LNR or LODDS: which is the most appropriate lymph node classification scheme for patients with radically resected pancreatic cancer? Cancers (Basel), 2022, 14(7): 1834. doi: 10.3390/cancers14071834.
|
17. |
Lei BW, Hu JQ, Yu PC, et al. Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer. Eur Arch Otorhinolaryngol, 2019, 276(12): 3425-3434.
|
18. |
Shetiwy M, Elalfy AF, Eldamshety O, et al. The prognostic significance of lymph node status and lymph node ratio (LNR) on survival of right colon cancer patients: a tertiary center experience. J Gastrointest Cancer, 2021, 52(3): 1010-1015.
|
19. |
Rozenblat T, Hirsch D, Robenshtok E, et al. The prognostic value of lymph node ratio in medullary thyroid carcinoma: a multi-center study. Eur J Surg Oncol, 2020, 46(11): 2023-2028.
|
20. |
王俊男, 闫枫尚, 徐拯, 等. 基于SEER数据库的甲状腺髓样癌预后因素分析. 中国普通外科杂志, 2018, 27(5): 547-552.
|
21. |
Chen L, Qian K, Guo K, et al. A Novel N staging system for predicting survival in patients with medullary thyroid cancer. Ann Surg Oncol, 2019, 26(13): 4430-4438.
|
22. |
Bae SY, Jung SP, Choe JH, et al. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma. Kaohsiung J Med Sci, 2019, 35(12): 772-777.
|
23. |
An Y, Lu J, Hu M, et al. A prediction model for the 5-year, 10-year and 20-year mortality of medullary thyroid carcinoma patients based on lymph node ratio and other predictors. Front Surg, 2023, 9: 1044971. doi: 10.3389/fsurg.2022.1044971.
|